Multi-Epitope-Based Vaccine Candidate for Monkeypox: An In Silico Approach.

Area of Science:

• Vaccinology
• Computational Biology
• Immunology

Background:

• Limited therapeutic interventions exist for monkeypox virus (MPXV) infections.
• Developing effective vaccines is crucial for controlling MPXV outbreaks.

Purpose of the Study:

• To computationally design a safe and immunogenic vaccine candidate against monkeypox.
• To predict the vaccine's stability and immune response capabilities using in silico methods.

Main Methods:

• Utilized immunoinformatics tools to identify T-cell epitopes (CTL, HTL, IFN-γ).
• Assessed vaccine safety through antigenic and allergic profiling.
• Evaluated vaccine-Toll-like receptor (TLR) interactions and stability via molecular dynamics simulations.
• Predicted immune response using C-IMMSIM simulation.

Main Results:

• Identified specific T-cell epitopes for vaccine construction.
• The designed vaccine exhibited favorable antigenic and allergenic profiles.
• Molecular dynamics simulations confirmed vaccine stability and interaction with TLRs.
• In silico simulations predicted a strong immune response against MPXV.

Conclusions:

• The in silico designed vaccine candidate shows promise for eliciting an effective immune response against monkeypox.
• Further experimental validation is necessary to confirm the safety and immunogenicity of the proposed vaccine.